Comment: Aspen-Pfizer court victory in Brazil may help other deals awaiting final CADE approval
Aspen Pharmacare and Pfizer have won a court battle over the Brazilian competition authority's temporary ban on closing deals until the agency's quorum is restored, MLex has learned. The confidential decision...To view the full article, register now.
Already a subscriber? Click here to view full article